Top Tweets for #MikeAtkins
Thank you for joining the session!
Thoughtful debates like the one between @brian_rini and #MikeAtkins on adjuvant therapy in RCC are exactly what @AUC3_Official is designed to showcase.
@OncoAlert @DrRanaMcKay @DrChoueiri @DrRosenbergMSK @montypal
#AUC3 #AUC3Miami #KidneyCancer #GUOncology #UrologyCare #CancerTreatmentAdvances #OncologyExperts #ClinicalDebate #CancerResearch #MedicalInnovation

Enjoyed the debate between @BrianRini & #MikeAtkins on the pros and cons of adjuvant therapy in RCC.
@AUC3_Official @OncoAlert
Enjoyed the debate between @BrianRini & #MikeAtkins on the pros and cons of adjuvant therapy in RCC.
@AUC3_Official @OncoAlert
OncoAlert🚨 Coverage of DAY ONE of #AUC3 2026
Presenter Dr. Brian Rini🇺🇸 (Adjuvant Therapy Debate) CON
Conclusions
There are relevant data points on both sides of the benefit:risk equation to consider in the application of adjuvant pembro in individual resected high-risk RCC patients
Benefits are real but modest with some missing information about the appropriate treatment of recurrence
Life-altering toxicity in patients who may not recur is sobering
RAMPART supports the benefit of adjuvant IO, and highlights confinement of the benefit to the highest risk patients
We need better prognostication tools and predictive/prognostic biomarkers (?KIM-1)
This is about to get more complicated with Pembro/belzu..
@DrRanaMcKay
@montypal
@DrRosenbergMSK
@Wanling50578056
@Dr_Aggen
@AlbigesL
@apolo_andrea
@OncoBellmunt
@bergsa83
@bilenma
@BraunMDPhD
@drjefstathiou
@PGrivasMDPhD
@shilpaonc
@arihakimi
@HHammersMD
@DrDanielHeng
@MichelleDunno17
@EJonasch
@koshkin85
@advocatekidneys
@UrogerliMD
@SurenaMatinMD
@maughanonc
@BradMcG04
@JoshMeeks
@motzermd
@AndreaNecchi
@SimaPorten
@tompowles1
@brian_rini
@sonpavde
@ChadTangMD
@MichvdHeijden
@VincentWenxinXu
@TiansterZhang
#kidneyCancer
#BladderCancer

5/ Led by @lena__wirth #MiyaHugaboom #KellyStreet, with #MikeAtkins #CathyWu and @hoosiercancer , we identify a population of exhausted CD8+ T cells expressing SLAMF7 and tissue residency markers that were associated with IO resistance @CD_AACR
https://t.co/qsQqLsX38i
@Uromigos #UromigosLive24 @brian_rini @tompowles1 ready to start the #Kidneyca session & controversial topics!
Watch it live!
@DrChoueiri @TiansterZhang @HHammersMD @AlbigesL #DaveMcdermott #MikeAtkins

Important 1st line #kidneycancer panel to banter IO-IO vs IO-TKI, cures and long term endpoints. Lively discussion. @Uromigos #UromigosLive @tompowles1 @brian_rini @DrChoueiri #DavidMcDermott #MikeAtkins

Congratulations #MikeAtkins — truly a giant in immunotherapy! Straight from #SITC23 to #UromigosLive!
@Uromigos #UromigosLive
Stimulating (&heated) debate about what regimen can cure mRCC pts?
1L mRCC IO/IO vs IO/TKI
@tompowles1 @DrChoueiri
@brian_rini
#DaveMcDermott #MikeAtkins
@HHammersMD @TiansterZhang @motzermd @DrRanaMcKay @PGrivasMDPhD
@neerajaiims @montypal

Someone asked me if we were conducting a seance to connect w each other and the spiritual world about #kidneycancer 😂
Always a privilege to discuss data w @brian_rini @Uromigos @PBarataMD #MikeAtkins!
In our roundtable discussion moderated by @brian_rini, experts @TiansterZhang, @PBarataMD, and Michael Atkins, MD discuss what is most exciting to them in the frontline RCC field, including a review of the OPTIC and PDIGREE trials. Watch now:
https://t.co/jByV3MDAH1

Must listen @Uromigos RCCs emergency podcasts Part 1 & 2 with @motzermd #MikeAtkins #DaveMcdermott triggered by the provocative Q&A session after RCC orals #ASCO23 @DrChoueiri @DrTHut @brian_rini @tompowles1
@montypal @neerajaiims @
The Q&A session for #kidneycancer was fiery 🔥🔥— cytokine & IO giants #MikeAtkins #NizarTannir giving challenges on “optimal IO” & trial costs in the US… @PGrivasMDPhD w astute Q about IO-rechallenge.
🙏🏼 thanks to @DrChoueiri w defense of #PDIGREE @ALLIANCE_org!! @asco #asco23

Wonderful #kidneycancer round table w #MikeAtkins, @brian_rini, @PBarataMD to discuss new RCC data 🔥🧡 @ASCO #ASCO23 @OncoAlert

Excellent talks from all top #IKCSEU23 abstract presenters #MikeAtkins @TheresaJunker @bendmercier @VerkarreVirgin2 @LuciaCarril2, session chaired by Dr. Lars Lund and @GabrielMalouf

#MikeAtkins with an astute look at propensity risk scoring for Checkmate214 & @hoosiercancer GU trials — ipi-nivo benefit driven still from the IMDC intermed-poor risk group. #IKCSEU23 @KidneyCancer @OncoAlert

An important panel on #clinicaltrials diversity and inclusion from @chana_weinstock #JosePerez #SHariharan #RickBangs, led by #MikeAtkins #KCRS22 @kidneycan

Great seeing the final analysis of #HCRN salvage ipi trial from #MikeAtkins! Upfront use of ipi-nivo preferred. @ASCO #GU22
Finishing up #GU22 Mike Atkins presents final results of nivo with salvage ipi at progression in met #kidneycancer - ORR in favorable risk surprisingly high 🤔 with nivo monotherapy c/w ipi nivo. Recommend: if giving pure IO therapy to poor int risk give nivo + ipi.

Here for the last session of #renalday - last day of @ASCO #GU22. Cases in #kidneycancer. @brian_rini @katy_beckermann #MikeAtkins @UroOncMD

Impressive follow-up data for tivo confirms an advantage over sorafenib, with a benefit that seems to be maintained over time. See our poster led by #MikeAtkins @Georgetown on Saturday at @ASCO #GU22 for complete data! @brian_rini @DrTHut

Vanderbilt is leading the charge in doing biomarker-based RCC trials. Thanks to all supporting this effort. @KimrynRathmell @katy_beckermann @VUMC_Cancer @montypal @MosheOrnsteinMD @TiansterZhang #mikeatkins

Reppin' @AtlJewishFilm + @WIFTAtlanta at @GA_Production 🎬✡️🎥 Intro by #MikeAtkins of... https://t.co/eE8VK0d334

Last Seen Hashtags on Sotwe
Most Popular Users

Elon Musk 
@elonmusk
241.2M followers

Barack Obama 
@barackobama
119.1M followers

Cristiano Ronaldo 
@cristiano
112.8M followers

Donald J. Trump 
@realdonaldtrump
111.8M followers

Narendra Modi 
@narendramodi
107.1M followers

Rihanna 
@rihanna
98.3M followers

NASA 
@nasa
92.3M followers

Justin Bieber 
@justinbieber
91.4M followers

KATY PERRY 
@katyperry
89M followers

Taylor Swift 
@taylorswift13
82.9M followers

Lady Gaga 
@ladygaga
74.4M followers

Virat Kohli 
@imvkohli
71.8M followers

Kim Kardashian 
@kimkardashian
70.4M followers

YouTube 
@youtube
68.8M followers

Neymar Jr 
@neymarjr
64.8M followers

Bill Gates 
@billgates
64.6M followers

The Ellen Show
@theellenshow
62.4M followers

Selena Gomez 
@selenagomez
62M followers

CNN 
@cnn
61.8M followers

X 
@x
60.8M followers




























